The post Vault Yields via Veda & Chaos Labs appeared on BitcoinEthereumNews.com. Users in North America and Europe will soon gain streamlined access to Kraken DefiThe post Vault Yields via Veda & Chaos Labs appeared on BitcoinEthereumNews.com. Users in North America and Europe will soon gain streamlined access to Kraken Defi

Vault Yields via Veda & Chaos Labs

Users in North America and Europe will soon gain streamlined access to Kraken Defi Earn through a new yield-focused product from the major crypto trading platform.

Kraken expands DeFi access with a new product to earn cryptocurrencies

Crypto exchange Kraken has introduced a new DeFi Earn product in Canada, the European Economic Area and most U.S. states, aiming to make onchain yields more accessible to its clients. The launch targets users who want exposure to decentralized finance without leaving the familiar environment of a centralized exchange.

The service will offer onchain earning opportunities with advertised annual percentage yields of up to 8%, according to an announcement shared today.

Moreover, Kraken emphasized that the product is designed to deliver the perceived simplicity and security of a traditional exchange interface while routing funds into decentralized protocols behind the scenes.

“With DeFi Earn, we are moving decentralized finance from a hobbyist’s pursuit to a mainstream financial utility,” Kraken Director John Zettler said. He added that the product aims to unlock real-time, transparent rewards in a way that feels intuitive to everyday users, arguing that this kind of offering can help bring decentralized finance to the “next billion” participants.

Centralized platforms race to build DeFi bridges

The launch arrives amid a broader push by centralized operators to act as a centralized defi bridge between traditional exchange users and onchain markets. Coinbase, for example, recently integrated Base-based DEX trading into its core platform, allowing customers to access decentralized liquidity from a familiar interface.

Meanwhile, custodians such as Anchorage have partnered with Spark to provide onchain lending yield on assets held in custody. However, many of these offerings still face the challenge of translating complex DeFi risk profiles into products suited for institutional and retail users who expect clear disclosures and smooth user experiences.

Veda vault infrastructure and USDC strategies

Kraken’s DeFi Earn will rely on vault infrastructure provider Veda to power the new offering, integrating its underlying technology to manage deposits and strategy execution. In addition, risk managers Chaos Labs and Sentora will operate the first three USDC vaults, which will serve as the initial strategies available to users at launch.

According to Kraken, those vaults will allocate funds to what it describes as “well-known onchain protocols” including Aave, Morpho, Sky and Tydro. Moreover, the exchange said the vaults are expected to generate variable USDC vault yields derived from actual market demand, with returns ultimately paid by borrowers using these lending and liquidity platforms.

This structure is intended to give users exposure to decentralized lending markets while maintaining a centralized point of access. That said, performance will still depend on protocol-level demand for borrowing and liquidity, as well as broader market conditions that influence utilization and interest rates across these DeFi protocols.

Risk management and institutional-grade infrastructure

The involvement of specialized firms underscores the focus on risk controls. Chaos Labs CEO Omer Goldberg argued that onchain yields have historically lacked the type of infrastructure and oversight institutions require. “Onchain yield has lacked the infrastructure institutions expect,” Goldberg said, pointing to the need for more robust safeguards around market and protocol risk.

“Launching Chaos Vaults on Kraken changes that, bringing AI-powered risk intelligence to millions of users and laying the foundation for how institutional-grade yield operates at scale,” he added. Furthermore, this positioning suggests Kraken is targeting not only retail users seeking defi earning opportunities but also more sophisticated clients that demand enhanced risk analytics and monitoring.

The partners say their approach is meant to create a framework that could later extend to additional assets and strategies. However, the long-term viability of any kraken defi earn strategy will depend on the continued reliability of the underlying protocols, as well as the effectiveness of Chaos Labs’ and Sentora’s risk management models in volatile market environments.

User experience, disclosures and withdrawals

Kraken stressed that transparency around returns and risks will be central to the user interface. DeFi Earn participants will receive clear alerts about offered rates, any applicable fees and potential risks before they commit funds to a vault. Moreover, users will be able to review this information on an ongoing basis as yields and market conditions change over time.

The exchange also outlined its withdrawal process, stating that redemptions are expected to be “typically instant.” However, Kraken cautioned that temporary delays may occur if liquidity in the underlying strategies becomes constrained, a risk inherent to onchain markets where capital can move quickly in response to changing incentives.

By embedding these disclosures directly into the product experience, Kraken aims to balance ease of use with clear communication about how DeFi-based yields are generated. In doing so, the platform is positioning its new Kraken Defi product as a gateway to onchain returns that still respects the expectations of users accustomed to centralized services.

Overall, Kraken’s partnership with Veda, Chaos Labs and Sentora seeks to merge institutional-style risk management with consumer-friendly access to decentralized yield, potentially expanding the audience for DeFi-based income products across Canada, the European Economic Area and most U.S. states.

Source: https://en.cryptonomist.ch/2026/01/26/kraken-defi-earn-launch/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26